Representative before the EPO

Company dna ep and c
no operation time available
3 offices
active in Legal Services

René John Raggers has worked on the following 4 EPO patent applications which have been published in the last five years:

EP11778231

IMMUNOTHERAPY USING REDIRECTED ALLOGENEIC CELLS

IPC classification:
C12N 5/02, C12N 15/11
Applicant:
Yeda Research and Development Co. Ltd.
Agent:
René John Raggers, Exter Polak & Charlouis B.V. (EP & C)
Status:
GRANT OF PATENT INTENDED
EP13795879

MEDICAL DEVICES WITH COATINGS FOR ENHANCED ECHOGENICITY

IPC classification:
A61L 31/08, A61L 31/18
Agent:
Cornelis Marinus Jansen, Vereenigde Octrooibureaux NV (V.O.)
Agent:
René John Raggers, Exter Polak & Charlouis B.V. (EP & C)
Status:
GRANT OF PATENT INTENDED
EP11725992

MIRNAS INVOLVED IN THE BLOOD BRAIN BARRIER FUNCTION

IPC classification:
A61K 31/713, A61P 25/00, A61P 27/02, A61P 31/18, A61P 35/00, C12N 15/113, C12Q 1/68
Applicant:
Vereniging voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek en Patiëntenzorg
Agent:
Thea van der Wijk, Nederlandsch Octrooibureau N.V.
Agent:
René John Raggers, Exter Polak & Charlouis B.V. (EP & C)
Status:
GRANT OF PATENT INTENDED
EP12193811

An improved mutagenesis method using polyethylene glycol mediated introduction of mutagenic nucleobases into plant protoplasts

IPC classification:
C12N 15/82
Applicant:
Keygene N.V.
Agent:
René John Raggers, Exter Polak & Charlouis B.V. (EP & C)
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature